 | ||||||
| "weight loss" | ||||||
| NEWS | ||||||
| Kindred Biosciences Inc (NASDAQ:KIN) has been downgraded to Hold in a statement by Zacks ... ... lead product candidates are Zimeta, which is indicated for the treatment of fever in horses, and KIND-010 for management of weight loss in cats.
| ||||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.